Scilex Holding (SCLXW) Cash & Equivalents (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Cash & Equivalents of $144.9 million in Q1 2026, up 2823.77% quarter-over-quarter from $5.0 million in Q4 2025, and up 2397.81% on a YoY basis from $5.8 million in Q1 2025.

Scilex Holding (SCLXW) Cash & Equivalents (2020 - 2026) Analysis & Trends

Scilex Holding's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $144.9 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 2397.81% year-over-year to $144.9 million; the TTM figure through Mar 2026 stood at $144.9 million (up 2397.81% YoY), while the FY2025 annual figure was $5.0 million, up 51.44% from the prior year.
  • Cash & Equivalents was $144.9 million for Q1 2026 at Scilex Holding, up from $5.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $144.9 million in Q1 2026 to a low of $34961.0 in Q3 2022.
  • Historically, Cash & Equivalents has averaged $13.0 million across 5 years, with a median of $3.3 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents soared 9613.84% in 2023, then slumped 96.15% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then dropped by 16.55% to $3.3 million in 2024, then soared by 51.44% to $5.0 million in 2025, then soared by 2823.77% to $144.9 million in 2026.
  • The last three Cash & Equivalents figures came in at $144.9 million (Q1 2026), $5.0 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 4.64 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.28 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 21.69 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 9.39 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 5.33 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 7.63 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.70 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 9.57 Bn
10 Scilex Holding - - 4.15 Mn 144.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 144.87 Mn
Dec 31, 2025 4.96 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.80 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 77,000.00
Jun 30, 2024 6.89 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 34.12 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 34,961.00
Jun 30, 2022 351,272.00
Mar 31, 2022 127,440.00
Dec 31, 2021 4.34 Mn
Sep 30, 2021 115,642.00
Jun 30, 2021 257,621.00